You are not logged in.

Request for Tenders - Supply of Antiretroviral Treatments

Details

Tender Closed
RFx ID : 19989635
Tender Name : Request for Tenders - Supply of Antiretroviral Treatments
Reference # : A1168708
Open Date : Monday, 6 August 2018 10:00 AM (Pacific/Auckland UTC+12:00)
Close Date  : Friday, 31 August 2018 4:00 PM (Pacific/Auckland UTC+12:00)
Tender Type : Request for Tenders (RFT)
Tender Coverage : Sole Agency  [?]
Categories :
  • 51000000 - Drugs and Pharmaceutical Products
Regions:
  • New Zealand
Exemption Reason : None
Required Pre-qualifications : None
Contact : Rob Turner
021858564
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Agency Address :
Overview

PHARMAC invites tenders for the supply of certain antiretroviral treatments to DHB Hospitals and to community pharmacies in New Zealand.

This request for tender (RFT) letter incorporates the following schedules:

(a) Schedule 1 sets out the definitions used in this RFT;
(b) Schedule 2 specifies the pharmaceuticals for which you may submit a Tender Bid in relation to community supply and/or hospital supply and provides background information to this RFT;
(c) Schedule 3 describes the process PHARMAC intends to follow in relation to this tender, and provides instructions on how to submit a Tender Bid in relation to community supply and/or hospital supply;
(d) Schedule 4 sets out terms that will apply if your Tender Bid in relation to community and/or hospital supply is awarded Sole Supply Status and/or Hospital Supply Status;
(e) Schedule 5 sets out the additional terms that will apply if your Tender Bid in relation to community supply is awarded Sole Supply Status;
(f) Schedule 6 sets out the additional terms that will apply if your Tender Bid in relation to hospital supply is awarded Hospital Supply Status; and
(g) Schedule 7 sets out any other special terms.

Please note that some clauses included in this RFT may not be applicable to this tender. PHARMAC has decided to retain substantially all of the clauses included in the standard PHARMAC invitation to tender to keep the terms of this RFT as familiar as possible to potential suppliers. This may mean that some clauses are not applicable in the context of a particular tender (which should be evident from the context).

For the avoidance of doubt, references in this RFT to “Price” and “subsidy” are references to the price at which a Pharmaceutical will be listed on the Pharmaceutical Schedule. Please also note the addition of Schedule 7, which sets out any terms not generally found in PHARMAC’s standard invitation to tender.

If you wish to submit a Tender Bid in relation to community supply and hospital supply, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 4pm (New Zealand time) on Friday 31 August 2018.

If you have any inquiries about this RFT please submit them via GETS.

We look forward to receiving your tender.

RFx Outcome

This tender has been awarded to:

  • AbbVie Limited
  • Gilead Sciences NZ
  • GlaxoSmithKline
  • Mylan New Zealand Ltd
  • TEVA Pharma (New Zealand) Limited

Further Award Information:
See website for details: https://www.pharmac.govt.nz/news/consultation-2018-10-16-antiretroviral/

Gilead: Emtricitabine 200 mg
AbbVie: Ritonavir 100 mg
GSK: Abacavir sulphate 300 mg
GSK Abacavir sulphate 600 mg with lamivudine 300 mg
Mylan: Efavirenz with emtricitabine and tenofovir disoproxil
Teva: Emtricitabine with tenofovir disoproxil
Teva: Atazanavir sulphate cap 150 mg and 200 mg

Award Date: Monday, 17 June 2019 (Pacific/Auckland UTC+12:00)
Date RFx was completed/updated: Monday, 1 October 2018 5:30 AM (Pacific/Auckland UTC+13:00)